Investor

Japan's AMED (Japan Agency for Medical Research and Development)

Last cheque observed Oct 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Growth equityQuiet

Series B

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque396days00hrs00min00sec
Median round$7.2MRounds led0 of 1
Pitch Japan's AMED (Japan Agency for Medical Research and Development)

Japan's AMED (Japan Agency for Medical Research and Development) highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2025

    1 round

  2. Oct
    Celaid TherapeuticsSeries B · JP · TechStartups$7.2MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Recently backed

The latest companies Japan's AMED (Japan Agency for Medical Research and Development) put money into.

Celaid Therapeutics$7.2M · Oct 2025

Quick answers about Japan's AMED (Japan Agency for Medical Research and Development)

What does Japan's AMED (Japan Agency for Medical Research and Development) invest in?

Japan's AMED (Japan Agency for Medical Research and Development) invests most often at Series B (100% of the rounds on record).

How active is Japan's AMED (Japan Agency for Medical Research and Development)?

1 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2025.

What has Japan's AMED (Japan Agency for Medical Research and Development) invested in recently?

Its most recent investments on record: Celaid Therapeutics (Series B, Oct 2025).

How big are Japan's AMED (Japan Agency for Medical Research and Development)'s cheques?

The median round it joins is $7.2M.

Is Japan's AMED (Japan Agency for Medical Research and Development) investing now?

No investments in the last 12 months; the latest was in Oct 2025.

What kind of investor is Japan's AMED (Japan Agency for Medical Research and Development)?

Japan's AMED (Japan Agency for Medical Research and Development) is a growth equity firm.

Where does this information on Japan's AMED (Japan Agency for Medical Research and Development) come from?

From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it